Using light stimulation to enhance vision after optic neuritis in multiple sclerosis patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This intervention aims to improve visual function in individuals with multiple sclerosis who have experienced optic neuritis by administering light stimulation. Participants will receive two daily sessions of 80 seconds of light stimulation over 12 days, using a flicker video on a mobile phone. A control group will receive sham stimulation to compare the outcomes. The primary focus is on measuring changes in high-contrast visual acuity, with secondary measures including colored-contrast tests.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Relapsing remitting multiple sclerosis or clinically isolated syndrome or no indication of chronic inflammatory central nervous system disease
* Age 18-60 years
* Optic neuritis within 1-3 months

Exclusion Criteria:

* Epilepsy
* Light-triggered migraine
* Insufficient vision correction
* Retinal disease (glaucoma, macular edema, macula degeneration, ...)

Where it's running

• Technical University of Munich
  Munich, Bavaria, Germany Recruiting

Study contacts

• Study coordinator: Philipp Gulde Gulde, Dr. phil.
• Email: philipp.gulde@tum.de
• Phone: 0049+8928924551

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Assessing eye changes in patients with multiple sclerosis

  This study is testing how changes in the eyes of people with multiple sclerosis relate to their condition, using advanced imaging techniques to see if these changes can help us understand the disease better.

  Recruiting Medical University of Vienna · Vienna, Austria · NCT03401879

• Privosegtor for optic neuritis: a late-phase test with standard care

  This trial tests whether privosegtor, added to the usual methylprednisolone treatment, helps people experiencing a first episode of optic neuritis.

  Recruiting at 4 sites Phase 3 Oculis · Livonia, Michigan and 3 other locations · NCT07623668

• Testing the 2022 Optic Neuritis Criteria in suspected cases of optic neuritis

  We’re trying to see if the 2022 criteria can correctly identify optic neuritis in patients with new or recent vision problems, including people with certain antibody types.

  Recruiting at 9 sites First Affiliated Hospital of Guangxi Medical University · Nanning, Guangxi and 8 other locations · NCT07623252

• Early versus rescue plasma exchange for severe optic neuritis and transverse myelitis

  This trial will see if starting plasma exchange early versus using it only as a rescue after high-dose steroids improves vision for adults with severe optic neuritis and improves neurologic recovery for adults with severe transverse myelitis.

  Recruiting at 32 sites Phase 3 Mayo Clinic · Birmingham, Alabama and 34 other locations · NCT07100990

• Slip-and-trip motor training to reduce falls in relapsing‑remitting multiple sclerosis

  This program tests whether repeated practice with controlled slips and trips helps ambulatory adults with relapsing‑remitting multiple sclerosis learn to react better and lower their chance of falling.

  Recruiting Georgia State University · Atlanta, Georgia · NCT06919900

• Effects of Ketogenic Diet on Multiple Sclerosis

  This study is testing whether a ketogenic diet or a Mediterranean diet can help people with relapsing-remitting multiple sclerosis feel better and manage their symptoms.

  Recruiting IRCCS National Neurological Institute "C. Mondino" Foundation · Pavia · NCT06715436

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.